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introduction: Alpha-lipoic acid (a-LA) is an antioxidant shown to ameliorate age- 
associated impairments of brain and cardiovascular function. Human milk is known to 
have high antioxidant capacity; however, the role of antioxidants in the developing brain 
is largely uncharacterized. This exploratory study aimed to examine the dose–response 
effects of a-LA on piglet growth and neurodevelopment.
Methods: Beginning at 2  days of age, 31 male pigs received 1 of 3 diets: control 
(CONT) (0 mg a-LA/100 g), low a-LA (LOW) (120 mg a-LA/100 g), or high a-LA (HIGH) 
(240 mg a-LA/100 g). From 14 to 28 days of age, pigs were subjected to spatial T-maze 
assessment, and macrostructural and microstructural neuroimaging procedures were 
performed at 31 days of age.
results: No differences due to diet were observed for bodyweight gain or intestinal 
weight and length. Spatial T-maze assessment did not reveal learning differences due 
to diet in proportion of correct choices or latency to choice measures. Diffusion tensor 
imaging revealed decreased (P = 0.01) fractional anisotropy (FA) in the internal capsule 
of HIGH-fed pigs compared with both the CONT (P < 0.01)- and LOW (P = 0.03)-fed 
pigs, which were not different from one another. Analysis of axial diffusivity (AD) within 
the internal capsule revealed a main effect of diet (P < 0.01) in which HIGH-fed piglets 
exhibited smaller (P < 0.01) rates of diffusion compared with CONT piglets, but HIGH-fed 
piglets were not different (P = 0.12) than LOW-fed piglets. Tract-based spatial statistics, 
a comparison of FA values along white matter tracts, revealed 1,650 voxels where CONT 
piglets exhibited higher (P < 0.05) values compared with HIGH-fed piglets.
conclusion: The lack of differences in intestinal and bodyweight measures among 
piglets indicate a-LA supplementation does not impact overall growth, regardless of 
concentration. Additionally, no observed differences between CONT- and LOW-fed pig-
lets in behavior and neuroimaging measures indicate a low concentration of a-LA does 
not affect normal brain development. Supplementation of a-LA at a high concentration 
appeared to alter white matter maturation in the internal capsule, which may indicate 
delayed neurodevelopment in these piglets.
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inTrODUcTiOn
Alpha-lipoic acid (a-LA), also known as thioctic acid, is an 
endogenously derived antioxidant found in animal and human 
cells alike, where it is a cofactor in mitochondrial dehydrogenase 
complexes. Although production of this dithiol occurs within 
the body, a-LA is known to be readily absorbed from the diet 
and is active in both aqueous and lipid-rich tissue. Lipoic acid 
is referred to as the “universal antioxidant” due to its multitude 
of functions including metal chelation, free radical quenching, 
antioxidant regeneration, and regulation of gene and protein 
expression (1). Moreover, provision of this molecule has been 
used for therapeutic treatments due its positive effects on diabetic 
polyneuropathy and age-associated impairments of cardiac and 
brain function (2, 3).
To date, much of research on a-LA supplementation has 
focused on its impact in the aging brain. Iron deposition that 
occurs in disease states such as Parkinson’s and Alzheimer’s 
increases occurrence of free radicals and peroxidation of 
polyunsaturated fatty acids (2). Dihydrolipoic acid (DHLA), 
the reduced form of a-LA, functions as a chelator of transition 
metals and may modulate the effects of excess iron on free radi-
cal production (4). Research shows supplementation of DHLA 
exerts a positive impact on the pathobiology of Alzheimer’s 
disease (5). Additionally, supplementation of a-LA attenuates 
age-related cognitive decline in aged mice, suggesting that age-
related oxidative stress might be a contributing factor in impaired 
memory formation (6, 7). However, the largest randomized 
clinical trial to date using a combination of antioxidants, includ-
ing a-LA, did not impact cerebrospinal fluid (CSF) biomarkers 
of tau and amyloid pathology and suggests treatment with this 
antioxidant combination results in faster cognitive decline. This 
clinical trial revealed differences in CSF F2-isoprostane levels, 
suggesting antioxidant supplementation reduces oxidative stress 
in the brain (8). Conflicting evidence on the efficacy of anti-
oxidant supplementation highlights the complexities of these 
compounds in neuroprotection and warrants further research. 
Specifically, a-LA appears to be sensitive to dose, route, and 
timing of administration across species (9). While there appear 
to be benefits to a-LA in brain oxidative stress, it is unclear how 
the antioxidant and neuroprotective effects of a-LA impact the 
developing brain.
The brain is one of the most highly metabolic organs in the 
body. It contains a high concentration of polyunsaturated fatty 
acids and accumulates redox-active metals, thereby rendering it 
susceptible to oxidative stress (10). Throughout development, the 
brain is operating in an increased metabolic state and is rapidly 
accreting polyunsaturated fatty acids and iron, all while operating 
with immature antioxidant systems (10). As such, the neonatal 
brain is likely at an increased risk of experiencing oxidative stress 
during this dynamic growth period. Because human milk is gen-
erally considered to be the optimal source of nutrient provision 
for the human infant, there exists a need to understand how its 
components, notably antioxidants, play a role in normal infant 
development. Analysis of human milk has revealed higher antioxi-
dant capacity compared with infant formulas, possibly  suggesting 
protective effects against oxidative stress exerted through human 
milk (11, 12). Presently, there appear to be no published reports 
on a-LA levels in human milk and a limited number of studies 
investigating the effects of a-LA on neurodevelopment. Provided 
that a-LA is considered a universal antioxidant, there is interest 
in understanding whether it may be beneficial in the context of 
pediatric nutrition.
Use of MRI techniques in the neonatal piglet has previously 
established the pig as a clinically relevant translatable model for 
human infants in the context of nutrition and neurodevelopment 
(13–17). To the best of our knowledge, no study has investigated 
the effects of a-LA supplementation in infant formula and its 
effects on the developing brain. Because infants, especially those 
born preterm, are susceptible to periods of oxidative stress, there 
exists a need to characterize antioxidants that might be included 
in infant formulas. As such, the aim of this exploratory study 
was to examine the dose–response effects of a-LA on growth, 
cognition, and structural brain development using the preclini-
cal piglet model. We hypothesized that supplementation of this 
readily absorbed molecule would confer neurodevelopmental 
changes quantified through magnetic resonance imaging, thus 
elucidating an optimal dose to support brain development.
MaTerials anD MeThODs
All animal care and experimental procedures were in compliance 
with National Research Council Guide for the Care and Use 
of Laboratory Animal Care and Use Committee and approved 
by the University of Illinois Urbana-Champaign Institutional 
Animal Care and Use Committee.
animals and housing
Thirty-eight vaginally derived intact male Yorkshire piglets from 
the University of Illinois Imported Swine Research Laboratory 
were obtained 48 h after birth, to allow for colostrum consump-
tion, and artificially reared over a 27 (replicate 1)- or 29 (replicates 
2 and 3)-day trial period. The trial was completed in 3 replicates 
(12–14 piglets per replicate), with piglets selected from 12 total 
litters to control for genetics and initial body weight. Piglets were 
housed individually in stainless steel cages with clear Plexiglass 
facades and side walls bearing small openings to allow for proper 
ventilation. Individual piglets had ad libitum access to water, as 
well as a rubber ball and towel for enrichment (16).
Ambient room temperature was maintained between 27 and 
29°C and heat lamps provided supplemental heat within the cage. 
A 12-h light/dark cycle was maintained with light from 0600 to 
1800 hours. Prior to placement in the artificial rearing system, 
piglets were administered 5  ml of Clostridium perfingens C. 
perfingens antitoxin C + D per manufacturer’s recommendations 
(Colorado Serum company, Denver, CO, USA). Piglets exhibiting 
sickness behavior, defined as diarrhea for more than 48 h, were 
placed on an electrolyte solution and administered a single dose 
of sulfamethoxazole and trimethoprim oral suspension [50 and 
8 mg/ml, respectively (Hi-tech Pharmacal, Amityville, NY, USA) 
for three consecutive days]. Piglets that failed to thrive were 
euthanized prior to study end.
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Dietary Treatments and Feeding 
Parameters
All researchers involved with conducting the study and acquiring 
and analyzing the study results remained blinded to identity of 
dietary treatments until final statistical analyses had been com-
pleted. Piglets were provided either a control (CONT) diet or the 
control diet supplemented with a low a-LA concentration (LOW) 
or high a-LA concentration (HIGH) for the duration of the feed-
ing trial. Concentrations of a-LA (Sodium R-Lipoate, GereoNova 
Research, Inc., Richmond, CA, USA) in test diets were formulated 
as follows: CONT (0 mg a-LA/100 g milk replacer powder), LOW 
(120 mg a-LA/100 g milk replacer powder), and HIGH (240 mg 
a-LA/100 g milk replacer powder). A prebiotic blend of polydex-
trose (PDX) and galactooligosaccharides (GOS) was provided 
in all dietary treatments as follows: (1.30 g/100 g milk replacer 
powder PDX, Danisco, Terre Haute, IN, USA; 2.70 g/100 g milk 
replacer powder GOS, FrieslandCampina, Zwolle, Netherlands). 
All dietary treatments were supplemented with docosahexaenoic 
acid (DHA) (91 mg/100 g milk replacer powder, DSM Nutritional 
Products, Kingstree, SC, USA) and arachidonic acid (ARA) 
(182 mg/100 g milk replacer powder, DSM Nutritional Products, 
Kingstree, SC, USA). Experimental piglet diets were manufac-
tured to human quality standards (Mead Johnson Pediatric 
Nutrition Institute, Evansville, IN, USA) with adjustments in the 
nutritional profile made to meet or exceed nutrient requirements 
for the neonatal pig (18).
All powdered milk replacer formula was reconstituted with 
200 g of dry powder per 800 g of water. Given this reconstitution 
rate, final formulated lipoic acid concentrations (milligram per 
liter) were as follows: CONT (0 mg a-LA/l), LOW (240 mg a-LA/l), 
and HIGH (480  mg a-LA/l). On the first day in the artificial 
rearing system, piglets received small volumes of milk formulas 
to provide an adjustment period prior to the standard feeding 
regimen. Piglets were fed at 285, 305, 310 ml of reconstituted diet 
per kilogram of BW starting on 3, 6, and 12 days of age, respec-
tively. Meal allotment was determined by recording daily body 
weight of individual piglets. Each diet was reconstituted fresh at 
each feeding and provided up to five times a day, approximately 
every 4  h, between 0700 and 2200 hours. Piglets were fasted 
prior to spatial T-maze assessment to incentivize the milk reward 
offered in the behavioral task. On days that cognitive assessment 
occurred (between 17 and 28 days of age) piglets were provided 
four meals instead of five, while maintaining the aforementioned 
daily volume per kilogram body weight feeding rate.
spatial T-Maze assessment
Spatial working memory was assessed using a validated behav-
ioral task in a specially designed T-maze for the young pig (19, 
20). Beginning at 15 days of age, piglets were subjected to 14 days 
of behavioral assessment, including an 8-day acquisition phase 
followed by a 6-day reversal phase. A detailed description of 
spatial T-maze assessment and piglet performance measures was 
previously described (15).
neuroimaging Procedures
At 29 (replicate 1) and 31 (replicates 2 and 3) days of age, 
piglets were subjected to magnetic resonance imaging (MRI) 
procedures. Scanning procedures were implemented on a 
Siemens MAGNETOM Trio 3 T Imager using a 32-channel head 
coil. Upon arrival to the Biomedical Imaging Center located in 
the Beckman Institute for Advanced Science and Technology, 
piglets were anesthetized via intramuscular injection of Telazol 
(0.07  mg/kg body weight; Zoetis, Florham Park, NJ, USA). 
Once sedated, piglets were transferred to the MRI scanner and 
maintained on 2% isoflurane/98% oxygen (Isoflurane, Piramal 
Healthcare, Bethlehem, PA, USA) for the entirety of the 60-min 
scan. Piglet vital signs were monitored throughout the scan using 
an MRI-compatible pulse oximeter, and upon completion of 
the scan, piglets were maintained under anesthesia and imme-
diately euthanized for tissue collection. Detailed methods for 
manual brain segmentation, volumetric assessment, voxel-based 
morphometry, and diffusion tensor imaging were previously 
described (15, 16).
Tract-Based spatial statistics
The FSL 5.0 toolbox was used for tract-based spatial statistics 
(TBSS) assessment of fractional anisotropy (FA) data. FA 
images, previously generated from diffusion data, were manually 
extracted, and all FA data from individual subjects were aligned 
using the FSL non-linear registration tool FNIRT. Upon align-
ment, the study-specific mean FA image was created, and a mean 
FA skeleton representing the center of all common tracts was 
established. A threshold of 0.2 was determined to be sensitive for 
mean FA tract delineation. Once the study-specific mean FA skel-
eton was created, each subjects’ aligned FA data were projected 
onto the mean FA skeleton and the resulting voxel-wise cross-
subject data were used for statistical analyses (21, 22). For all 
TBSS analyses involving registration to an atlas, the Piglet Brain 
Atlas (http://pigmri.illinois.edu/) was used in place of human 
brain templates (23). For TBSS analysis, only piglets receiving 
the CONT and HIGH diets were compared. A non-parametric 
permutation inference function called “randomize” was used 
within the FSL toolbox and run as a two-sample t-test with 500 
permutations. Multiple comparisons were also accounted for 
within the randomize function. The resulting statistical analysis 
was then presented as heat maps indicating brain areas where FA 
values differed between dietary treatments.
small intestine Tissue collection
Immediately following magnetic resonance imaging procedures 
(described above) and while remaining under anesthesia, piglets 
were euthanized via intracardiac administration of sodium 
pentobarbital (86.0  mg/kg of body weight; Fatal Plus, Vortech 
Pharmaceuticals, Dearborn, MI, USA). Following euthanasia, 
brain and small intestinal tissues were collected. The entire 
small intestine (i.e., extending from the pyloric sphincter to the 
ileocecal valve) was removed and immediately measured for total 
length. The small intestine was further dissected into three seg-
ments: duodenum (proximal 10%), jejunum (middle 75%), and 
ileum (distal 15%). All sections were flushed with saline prior to 
being weighed, as described previously (24). Data were expressed 
both on an absolute basis and relative to the final bodyweight of 
individual piglets.
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FigUre 1 | Piglet daily bodyweight. Average body weight of each dietary treatment group over 28-day trial period (n = 10–11 per treatment); there was no 
observed interactive effect of treatment × day for daily bodyweight and no main effect of treatment, only a main effect of day was observed (P < 0.001).
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statistical analysis
An analysis of variance (ANOVA) was conducted using the 
MIXED procedure of SAS 9.4 (SAS Inst. Inc., Cary, NC, USA) 
and was applied to differentiate the effects of the CONT, LOW, 
and HIGH diets provided to young pigs. For outcomes col-
lected at a single time-point (i.e., brain volume and DTI, tissue 
weight and length), data were analyzed by a one-way ANOVA. 
Any data collected from the same animal on more than one 
occasion (i.e., daily bodyweights and behavioral assessment) 
were analyzed as a two-way, repeated-measures ANOVA. Both 
statistical models included replicate as a random effects and the 
level of significance was set at P < 0.05 with trends accepted at 
0.05 < P < 0.10.
resUlTs
Piglet growth and health
Overall, there was no observed interactive effect (i.e., diet × day; 
P = 0.229) or the main effect of diet (0.463) for daily bodyweight 
throughout the feeding trial. However, a main effect of day 
(P < 0.001) was evident (Figure 1). Over the course of this study, 
seven piglets failed to thrive due to sickness unrelated to dietary 
treatment (CONT: n =  2; LOW: n =  2; HIGH: n =  3) and as 
such were euthanized prior to study end. Thus, only 31 piglets are 
included in the subsequent analyses.
intestinal growth
No main effect of diet was observed for small intestinal length 
(P = 0.949) or total absolute (P = 0.783) or relative (P = 0.216) 
intestinal weights (data not shown). Moreover, absolute weight 
of each small intestinal segment did not differ by diet [duode-
num (P = 0.711), jejunum (P = 0.870), and ileum (P = 0.415)], 
and neither did relative intestinal segment weights [duodenum 
(P = 0.072), jejunum (P = 0.154), and ileum (P = 0.444)] (data 
not shown).
Behavior Performance
Using piglet participation criteria set forth previously (15), four 
piglets were excluded from behavioral analysis as they displayed 
at least 3 days of non-compliance during the behavioral testing 
period. As such, the total number of piglets included in the 
behavioral analysis was 27 (CONT, n = 10; LOW, n = 8; HIGH, 
n = 9). Additionally, one piglet (CONT diet) had 1 day of acquisi-
tion and 1  day of reversal removed and another piglet (HIGH 
diet) had 1 day of acquisition removed, all due to non-compliance 
on those days.
Analysis of proportion of correct choices during the acqui-
sition phase indicated no interactive effect (i.e., diet  ×  day) 
(P = 0.207) or main effect of diet (P = 0.580); only a main effect of 
day (P = 0.019) was observed (Figure 2). Additionally, latency to 
choice during the acquisition phase exhibited no interactive effect 
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FigUre 2 | spatial T-maze assessment. (a) No diet × day interaction or 
main effect of diet was observed in proportion of correct choices on each 
day. Only a main effect of day (P < 0.05) was observed for proportion of 
correct choice. (B) No diet × day interaction or main effect of diet was 
observed in latency to choice on each day. Only a main effect of day 
(P < 0.05) was observed for latency to choice. CONT, LOW, and HIGH 
treatments were formulated to contain 0, 240, and 480 mg alpha-lipoic acid 
per liter of reconstituted milk replacer, respectively. (A = acquisition, 8-day 
phase; R = reversal, 6-day phase).
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FigUre 3 | internal capsule axial diffusivity and fractional anisotropy. 
(a) A main effect (P < 0.01) of dietary treatment was observed for internal 
capsule axial diffusivity (AD). (B) A main effect (P = 0.01) of dietary treatment 
was observed for internal capsule fractional anisotropy (FA). CONT, LOW, and 
HIGH treatments were formulated to contain 0, 240, and 480 mg alpha-lipoic 
acid per liter of reconstituted milk replacer, respectively. abMeans without a 
common superscript letter differ (P < 0.05).
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(P = 0.720) or main effect of diet (P = 0.963); only a main effect of 
day (P = 0.001) was observed. Analysis of proportion of correct 
choices during the reversal phase also indicated no interactive 
effect (P = 0.637) or main effect of diet (P = 0.645); only a main 
effect of day (P = 0.001) was observed. Finally, latency to choice 
during the reversal phase resulted in no observed interactive 
effect (P = 0.587), main effect of diet (P = 0.105), or main effect 
of day (P = 0.824).
Volumetric assessment
No differences in absolute total brain volume were observed 
between dietary treatments (P = 0.25; data not shown). Analysis 
of absolute volumes of individual brain regions also resulted in no 
volumetric differences due to diet (P > 0.247; data not shown). 
Absolute volumes of individual brain regions were analyzed 
relative to total brain volume within subject, and relative propor-
tion of total brain volume was analyzed for each region. Dietary 
treatment tended (P = 0.087) to affect cerebellar relative volume, 
in which piglets provided the HIGH diet had a proportionally 
larger cerebellum (P = 0.037) compared with LOW-fed piglets. 
No differences due to diet were observed for any relative total 
volume of individual brain regions (P > 0.139).
Diffusion Tensor imaging
Diffusion tensor imaging revealed a main effect of diet (P < 0.05) 
in the internal capsule axial diffusivity (AD) and FA measures 
(Figure 3). A main effect (P < 0.01) of dietary treatment was 
observed for internal capsule AD, with piglets provided the 
HIGH diet exhibiting smaller (P < 0.01) AD values compared 
with CONT piglets, but they were not different (P =  0.124) 
than LOW-fed piglets. Low-fed piglets tended to have smaller 
(P =  0.064) internal capsule AD values when compared with 
CONT piglets. A main effect of diet (P  =  0.012) was also 
observed in internal capsule FA measures. Piglets provided the 
HIGH diet exhibited lower FA values compared with CONT 
(P <  0.01)- and LOW (P =  0.029)-fed piglets. No difference 
TaBle 1 | Thalamic and cerebellar diffusion measures tended to differ 
(P < 0.10) between dietary treatments.
region of 
interest
DTi 
measure
Diet Pooled P-value
cOnT lOW high seM
Thalamus ADc 1.213a 1.218ab 1.277b 0.021 0.0627
Thalamus RDc 0.750ab 0.747a 0.783b 0.012 0.0904
Thalamus MDc 0.904a 0.904a 0.948b 0.014 0.0569
Cerebellum FAd 0.1851b 0.1842ab 0.1688a 0.0053 0.0666
CONT, LOW, and HIGH treatments were formulated to contain 0, 240, and 480 mg of 
alpha-lipoic acid per liter of reconstituted milk replacer, respectively.
AD, axial diffusivity; RD, radial diffusivity; MD, mean diffusivity; FA, fractional anisotropy.
abMeans that do not have a similar letter superscript differ (P < 0.05), i.e., “ab” does not 
differ from “a” or “b”.
c×10−3 mm2/s.
dArbitrary FA values.
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between CONT- and LOW-fed piglets was observed in internal 
capsule FA values.
The main effect of diet tended to be significant (P < 0.10) for 
AD, radial diffusivity (RD), and mean diffusivity (MD) measures 
of the thalamus (Table  1). In all cases, no differences between 
CONT- and LOW-fed piglets were observed. Analysis of thalamic 
AD values revealed piglets provided the HIGH diet exhibited 
higher AD values compared with CONT (P = 0.031)- and LOW 
(P = 0.054)-fed piglets. Moreover, piglets provided the HIGH diet 
exhibited higher RD values compared with CONT (P = 0.066)- 
and LOW (P = 0.049)-fed piglets. MD values within the thala-
mus were also noted, with piglets fed the HIGH diet exhibiting 
higher MD values compared with CONT (P = 0.035)- and LOW 
(P = 0.038)-fed piglets. Finally, the main effect of diet tended to 
be significant for FA values in the cerebellum (P = 0.067). Piglets 
provided the HIGH diet exhibited lower FA values compared 
with CONT (P = 0.036)- and LOW (P = 0.052)-fed piglets, but no 
difference in cerebellar FA values was observed between CONT- 
and LOW-fed piglets.
Tract-Based spatial statistics
Tract-based spatial statistical analysis revealed 1,650 voxels within 
the predetermined white matter tracts in which CONT piglets 
exhibited higher (P < 0.05) FA values compared with HIGH-fed 
piglets (Figure  4). There were no significant differences in FA 
values along the predetermined white matter tracts in which the 
reverse was true (i.e., where HIGH-fed piglets exhibited higher 
FA values compared with CONT piglets).
DiscUssiOn
Piglets in this study were supplemented with varying levels of 
a-LA from 2 to 31 days of age to determine the impact of a-LA 
supplementation on overall body growth and brain development. 
Most antioxidant research to date focuses on the effects of sup-
plementation in the context of brain aging, with very little focusing 
on the needs and efficiency of antioxidants throughout neurode-
velopment. It is known that infants, notably preterm infants and 
those having experienced intrauterine growth restriction, are at 
an increased risk for oxidative stress due to immature antioxidant 
systems and elevated metabolic rates, polyunsaturated fatty acid 
concentrations, and non-protein bound iron concentrations (2, 
25). As such, supplementation of antioxidants to alleviate oxida-
tive stress during a highly dynamic growth period might confer 
benefits to normal growth and development. In our study, we 
observed that oral supplementation of the HIGH dose of a-LA 
resulted in altered internal capsule development, suggestive of 
delayed brain maturation. Moreover, there appeared to be a dose–
response with the LOW concentration group being intermediate 
to the CONT- and HIGH-fed piglets for many outcomes. These 
data are consistent with other studies of antioxidants in which sup-
plementation of high concentrations appear to exert detrimental 
effects on neuronal cell cultures (26–28). Although differences in 
brain development were evident among supplementation groups, 
provision of a-LA at any level did not affect bodyweight gain or 
intestinal maturation of piglets. Because there were no gross dif-
ferences in these measures, we suggest that the observed brain dif-
ferences were not due to overall piglet size or intestinal maturation 
of the piglets, rather it was directly due to oral supplementation 
of a-LA.
In this study, learning and memory were assessed using a spatial 
T-maze behavioral task. Over the course of the 8-day acquisition 
period and the 6-day reversal period, there was no observed effect 
of diet on piglet performance in proportion of correct choices. 
Moreover, piglet latency to choice also did not differ between 
dietary treatment groups throughout the acquisition or reversal 
phases. A main effect of day was observed for proportion of cor-
rect choices during acquisition and reversal, indicating learning 
did in fact occur. These behavioral observations appear to be 
consistent with previous studies where a-LA supplementation 
improved memory in aged mice, but not in young mice (6, 7). It 
should be noted that the young mice used in these studies were 
3 months of age, thus being equivalent to an adolescent, rather 
than neonatal, piglet, or human. However, it was suggested from 
these studies that supplementation of a-LA may compensate for 
age-related long-term memory deficits rather than enhancing 
overall memory in a developing brain.
Diffusion tensor measures revealed differences due to diet in 
AD and FA within the internal capsule. For both the FA and AD 
measures, an apparent dose–response was evident with CONT 
piglets consistently exhibiting the highest values, HIGH piglets 
exhibiting the lowest values, and LOW piglets being intermediate 
to the other two treatment groups. Interestingly, analysis of AD 
and FA in the internal capsule revealed LOW piglets were not dif-
ferent than CONT piglets, suggesting that the LOW dose of a-LA 
supports normal internal capsule development in the piglet. AD is 
most commonly described as a measurement of water movement 
along an axon tract. As development occurs, fiber coherence and 
myelination increase, thus increasing AD measures. Additionally, 
FA values tend to increase in brain regions as myelination occurs 
(29). A recent study in piglets of similar age also suggested altera-
tions in internal capsule development due to dietary interven-
tion, further confirming sensitivity of this brain region to early 
life nutritional interventions (15). Therefore, the decreased AD 
and FA values observed in HIGH piglets compared with CONT 
piglets suggests delayed development within the internal capsule 
at this time-point.
FigUre 4 | White matter tract fractional anisotropy differences. Fractional anisotropy differences along predetermined white matter tracts in which CONT 
piglets exhibited higher (P < 0.05) FA values compared with HIGH piglets. The images generated are an average of all piglet brains from this study, green lines signify 
regions in which all piglets exhibited white matter voxels. Representative slices were chosen to highlight areas in which FA values in CONT piglets were significantly 
different when compared with HIGH piglets, noted as red–yellow voxels. (a) Axial slices, with varying X-coordinates and static Y = 103 and Z = 110 coordinates, 
determined using the Piglet Brain Atlas (23). (B) Coronal slices, with varying Y-coordinates and static X = 68 and Z = 78 coordinates, determined using the Piglet 
Brain Atlas. Red and yellow colors indicate degree of statistical difference from P = 0.05 to P = 0.0001, respectively (23).
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